Download PDF
Thromb Haemost 1990; 63(02): 193-203
DOI: 10.1055/s-0038-1645194
Original Article
Schattauer GmbH Stuttgart

Characterization of a Mode of Specific Binding of Fibrin Monomer through its Amino-Terminal Domain by Macrophages and Macrophage Cell-Lines

John R Shainoff
The Research Institute of The Cleveland Clinic Foundation, Cleveland, OH, USA
,
Deborah J Stearns
The Research Institute of The Cleveland Clinic Foundation, Cleveland, OH, USA
,
Patricia M DiBello
The Research Institute of The Cleveland Clinic Foundation, Cleveland, OH, USA
,
Youko Hishikawa-Itoh
The Research Institute of The Cleveland Clinic Foundation, Cleveland, OH, USA
› Author Affiliations
Further Information

Publication History

Received 26 June 1989

Accepted after revision 27 November 1989

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The studies reported here probe the existence of a receptor-mediated mode of fibrin-binding by macrophages that is associated with the chemical change underlying the fibrinogen-fibrin conversion (the release of fibrinopeptides from the amino-terminal domain) without depending on fibrin-aggregation. The question is pursued by 1) characterization of binding in relation to fibrinopeptide content of both the intact protein and the CNBr-fragment comprising the amino-terminal domain known as the NDSK of the protein, 2) tests of competition for binding sites, and 3) photo-affinity labeling of macrophage surface proteins. The binding of intact monomers of types lacking either fibrinopeptide A alone (α-fibrin) or both fibrinopeptides A and B (αβ-fibrin) by peritoneal macrophages is characterized as proceeding through both a fibrin-specific low density/high affinity (BMAX ≃ 200–800 molecules/cell, KD ≃ 10−12 M) interaction that is not duplicated with fibrinogen, and a non-specific high density/low affinity (BMAX ≥ 105 molecules/cell, KD ≥ 10−6 M) interaction equivalent to the weak binding of fibrinogen. Similar binding characteristics are displayed by monocyte/macrophage cell lines (J774A.1 and U937) as well as peritoneal macrophages towards the NDSK preparations of these proteins, except for a slightly weaker (KD ≃ 10−10 M) high-affinity binding. The high affinity binding of intact monomer is inhibitable by fibrin-NDSK, but not fibrinogen-NDSK. This binding appears principally dependent on release of fibrinopeptide-A, because a species of fibrin (β-fibrin) lacking fibrinopeptide-B alone undergoes only weak binding similar to that of fibrinogen. Synthetic Gly-Pro-Arg and Gly-His-Arg-Pro corresponding to the N-termini of to the α- and the β-chains of fibrin both inhibit the high affinity binding of the fibrin-NDSKs, and the cell-adhesion peptide Arg-Gly-Asp does not. Photoaffinity-labeling experiments indicate that polypeptides with elec-trophoretically estimated masses of 124 and 187 kDa are the principal membrane components associated with specifically bound fibrin-NDSK. The binding could not be up-regulated with either phorbol myristyl acetate, interferon gamma or ADP, but was abolished by EDTA and by lipopolysaccharide. Because of the low BMAX, it is suggested that the high-affinity mode of binding characterized here would be too limited to function by itself in scavenging much fibrin, but may act cooperatively with other, less limited modes of fibrin binding.

 

  • References

  • 1 Bailey K, Bettelheim FR, Lorand L, Middlebrook WR. Action of thrombin in clotting of fibrinogen. Nature 1951; 167: 233-234
    CrossrefPubMedGoogle Scholar
  • 2 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-3089
    CrossrefPubMedGoogle Scholar
  • 3 Kudryk B, Collen D, Woods KR, Blombäck B. Evidence for localization of polymerization sites in fibrinogen. J Biol Chem 1974; 249: 3322-3325
    PubMedGoogle Scholar
  • 4 Shainoff JR, Dardik BN. Fibrinopeptide B and aggregation of fibrinogen. Science 1979; 204: 200-202
    CrossrefPubMedGoogle Scholar
  • 5 Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci USA 1980; 77: 1374-1378
    CrossrefPubMedGoogle Scholar
  • 6 Varadi A, Scheraga HA. Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen. Biochemistry 1986; 25: 519-528
    CrossrefPubMedGoogle Scholar
  • 7 Marder VJ, Shulman NR. High molecular weight derivatives of human fibrinogen produced by plasmin. J Biol Chem 1969; 244: 2111-2119
    PubMedGoogle Scholar
  • 8 Shainoff JR, Page IH. Significance of cryoprofibrin in fibrinogen-fibrin conversion. J Exp Med 1962; 116: 687-707
    CrossrefPubMedGoogle Scholar
  • 9 Godal HC, Abilgaard V. Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol 1966; 3: 342-350
    PubMedGoogle Scholar
  • 10 Shainoff JR, Page IH. Cofibrins and fibrin-intermediates as indicators of thrombin activity in vivo. Circ Res 1960; 8: 1013-1022
    CrossrefPubMedGoogle Scholar
  • 11 Rodriguez-Erdman F. Bleeding due to increased intravascular blood coagulation. Hemorrhagic syndromes caused by consumption of blood clotting factors (Consumption-Coagulopathies). N Engl J Med 1965; 273: 1370-1378
    PubMedGoogle Scholar
  • 12 Lee L, McCluskey RT. Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates. J Exp Med 1962; 116: 611-621
    CrossrefPubMedGoogle Scholar
  • 13 Sherman LA, Harwig S, Lee J. In vitro formation and in vivo clearance of fibrinogen, fibrin complexes. J Lab Clin Med 1975; 86: 100-111
    PubMedGoogle Scholar
  • 14 Sherman LA, Lee J, Jacobsen A. Quantitation of the reticuloendothelial system clearance of soluble fibrin. Br J Haematol 1977; 37: 231-238
    CrossrefPubMedGoogle Scholar
  • 15 Dardik BN, Shainoff JR. Kinetic characterization of a saturable pathway for rapid clearance of circulating fibrin monomer. Blood 1985; 65: 680-688
    CrossrefPubMedGoogle Scholar
  • 16 MÜller-Berghaus G, Mahn T, Koveker G, Maul FD. In vivo behavior of homologous urea-soluble 131I and 125I-fibrin-fibrinogen in rabbits: The effect of fibrinolytic inhibitors. Br J Haematol 1961; 33: 61-79
    PubMedGoogle Scholar
  • 17 Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Schwartzman reaction. J Exp Med 1962; 115: 1065-1082
    CrossrefPubMedGoogle Scholar
  • 18 Colvin RB, Dvorak HF. Fibrinogen/fibrin on the surface of macrophages: Detection, distribution, binding requirements and possible role in macrophage adherence phenomena. J Exp Med 1975; 142: 1377-1390
    CrossrefPubMedGoogle Scholar
  • 19 Jilek F, Hörmann H. Fibronectin (cold-insoluble globulin): Mediation of fibrin monomer binding to macrophages. Hoppe-Seylers Z Physiol Chem 1978; 359: 1603-1605
    PubMedGoogle Scholar
  • 20 Hopper KE, Geczy CL, Davies WA. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. I. Fibrin deposition on the surface of elicited peritoneal macrophages in vivo. J Immunol 1981; 126: 1052-1058
    PubMedGoogle Scholar
  • 21 Sherman LA, Lee J. Specific binding of soluble fibrin to macrophages. J Exp Med 1977; 145: 76-85
    CrossrefPubMedGoogle Scholar
  • 22 Gonda SR, Shainoff JR. Adsorptive endocytosis of fibrin monomer by macrophages: Evidence of a receptor for the amino terminus of the fibrin a chain. Proc Natl Acad Sci USA 1982; 79: 4565-4569
    CrossrefPubMedGoogle Scholar
  • 23 Blombäck B, Blombäck M, Henschen A, Hessel B, Iwanaga S, Woods KR. N-terminal disulphide knot of human fibrinogen. Nature 1968; 218: 130-134
    CrossrefPubMedGoogle Scholar
  • 24 Kowalska-Loth B, Garlund B, Egberg N, Blombäck B. Plasmic degradation products of human fibrinogen. II. Chemical and immunological relation between fragment E and NDSK. Thromb Res 1973; 2: 423-450
    PubMedGoogle Scholar
  • 25 Marder VJ, Budzynski AZ, James HL. High molecular weight derivatives of human fibrinogen produced by plasmin. III. Their NH2-terminal amino acids and comparison with the “NH2-terminal disulfide knot”. J Biol Chem 1972; 247: 4775-4781
    PubMedGoogle Scholar
  • 26 Scheraga HA, Laskowski Jr J. The fibrinogen-fibrin conversion. Adv Protein Chem 1957; 12: 1-131
    CrossrefPubMedGoogle Scholar
  • 27 Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC–1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 1988; 107: 1893-1900
    CrossrefPubMedGoogle Scholar
  • 28 Kradin RL, Lynch GW, Kurnick JT, Erikson M, Colvin RB, McDonagh J. Factor XIIIA is synthesized and expressed on the surface of U937 cells and alveolar macrophages. Blood 1987; 69: 778-785
    PubMedGoogle Scholar
  • 29 Unanue ER, Allen PM. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 1987; 236: 551-557
    CrossrefPubMedGoogle Scholar
  • 30 Lam SC T, Plow EF, Smith MA, Andrieux A, Ryckwaert J-J, Marguerie G, Ginsberg MH. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen γ chain peptides share a common binding site on platelets. J Biol Chem 1987; 262: 947-950
    PubMedGoogle Scholar
  • 31 Straughn WIII, Wagner RH. A simple method for preparing fibrinogen. Thromb Diathes Haemorrh 1966; 16: 198-206
    PubMedGoogle Scholar
  • 32 Shainoff JR, Lahiri B, Bumpus FM. Ultracentrifuge studies on the reaction between thrombin and plasminized fibrinogen. Thromb Diathes Haemorrh 1970; (Suppl. 39) 203-217
    PubMedGoogle Scholar
  • 33 Finlayson JS, Mosesson MW. Heterogeneity of human fibrinogen. Biochemistry 1963; 2: 42-46
    CrossrefPubMedGoogle Scholar
  • 34 Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrin stabilizing factor (Factor XIIIa). J Lab Clin Med 1976; 85: 574-597
    PubMedGoogle Scholar
  • 35 Herzig RH, Ratnoff OD, Shainoff JR. Studies on a procoagulant fraction of southern copperhead snake venom: The preferential release of fibrinopeptide B. J Lab Clin Med 1970; 76: 451-465
    PubMedGoogle Scholar
  • 36 Garlund B, Kowalska-Loth B, Grondahl NJ, Blombäck B. Plasmic degradation products of human fibrinogen. I. Isolation and characterization of fragments E and D and their relation to “disulfide knots”. Thromb Res 1972; 1: 371-388
    PubMedGoogle Scholar
  • 37 Garlund B, Kowalska-Loth B, Grondahl NJ, Blombäck B. Hydro-phobic disulfide knots in human fibrinogen. III Congress, Int Soc Thromb Haemostas 1972; 92
    PubMedGoogle Scholar
  • 38 Blombäck B, Blombäck M, Hessel B, Finkbeiner W. Properties of N-terminal “disulfide knots” of human fibrinogen. III Congress, Int Soc Thromb Haemostas 1972; 70
    PubMedGoogle Scholar
  • 39 Shainoff JR. Zonal immobilization of proteins. Biochem Biophys Res Comm 1980; 95: 690-695
    CrossrefPubMedGoogle Scholar
  • 40 McFarlane AS. In vivo behavior of 131I-fibrinogen. J Clin Invest 1963; 42: 346-360
    CrossrefPubMedGoogle Scholar
  • 41 Nisonoff A, Wissler FC, Lipman LN, Woernly DL. Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys 1960; 89: 230-244
    CrossrefPubMedGoogle Scholar
  • 42 Labarca C, Paigen K. A simple, rapid and sensitive DNA assay procedure. Anal Biochem 1980; 102: 344-352
    CrossrefPubMedGoogle Scholar
  • 43 McPherson GA. Kinetic, EBDA, Ligand, Lowry, A Collection of Radioligand Binding Analysis Programs. Elsevier-BIOSOFT® ; Cambridge, UK: 1985
  • 44 Bennett JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
    CrossrefPubMedGoogle Scholar
  • 45 Ji I, Ji TH. Macromolecular photoaffinity labeling with radioactive photoactivatable heterobifunctional reagents. Anal Biochem 1982; 121: 286-289
    CrossrefPubMedGoogle Scholar
  • 46 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 47 Pratten MK, Lloyd JB. Effects of temperature, metabolic inhibitors and some other factors on fluid-phase and adsorptive pinocytosis by rat peritoneal macrophages. Biochem J 1979; 180: 567-571
    CrossrefPubMedGoogle Scholar
  • 48 Loken MR, Herzenberg LA. Analysis of cell populations with a fluorescence-activated cell sorter. Ann N Y Acad Sci 1975; 254: 163-171
    CrossrefPubMedGoogle Scholar
  • 49 Shainoff JR, Dardik BN. Fibrinopeptide B in fibrin assembly and metabolism: physiologic significance in delayed release of the peptide. Ann N Y Acad Sci 1983; 408: 254-268
    CrossrefPubMedGoogle Scholar
  • 50 Rajagopalan S, Pizzo SV. Characterization of murine peritoneal macrophage receptors for fibrin(ogen) degradation products. Blood 1986; 67: 1224-1228
    PubMedGoogle Scholar
  • 51 Ehrlich H, Delvos U, Mliller-Berghaus G. Binding characteristics of soluble fibrin to alveolar macrophages. X Congr Int Soc Thromb Haemostas 1985; p 108
    PubMedGoogle Scholar
  • 52 Ferry JD, Shimizu A. Comparisons of clots of α-, β-, and αβ-fibrin: Mechanical properties and interaction with fibrinogen-binding tet-rapeptides. In: Fibrinogen 3. Biochemistry, biological functions, gene regulation and expression Mosesson MW, Amrani DL, Siebenlist KR, Diorio JP. (eds) Elsevier; Amsterdam: 1988. pp 87-90
  • 53 Bevilacqua MP, Amrani D, Mosesson MW, Bianco C. Receptors for cold-insoluble globulin (plasma fibronectin) on human monocytes. J Exp Med 1981; 153: 42-60
    CrossrefPubMedGoogle Scholar
  • 54 Hörmann H, Richter H, Jelinic V. Fibrin monomer binding to macrophages mediated by fibrin-binding fibronectin fragments. Thromb Res 1985; 38: 183-194
    PubMedGoogle Scholar
  • 55 Dejana E, Vergara-Dauden M, Balconi G, Pietra A, Cherel G, Donati MB, Larrieu M, Marguerie G. Specific binding of human fibrinogen to cultured human fibroblasts: Evidence for involvement of the E domain. Eur J Biochem 1984; 139: 657-662
    CrossrefPubMedGoogle Scholar
  • 56 Dejana E, Languino LR, Polentarutti N, Balconi G, Ryckewaert JJ, Larrieu MJ, Donati MB, Mantovani A, Marguerie G. Interaction between fibrinogen and cultured endothelial cells: Induction of migration and specific binding. J Clin Invest 1985; 75: 11-18
    CrossrefPubMedGoogle Scholar
  • 57 Haverkate F, Timan G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. Thromb Res 1977; 10: 803-812
    CrossrefPubMedGoogle Scholar
  • 58 Hynes RO. Integrins: A family of cell surface receptors. Cell 1987; 48: 549-554
    CrossrefPubMedGoogle Scholar
  • 59 Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science. 1987; 238: 491-497
    PubMedGoogle Scholar
  • 60 Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemostas 1988; 59: 1-6
    PubMedGoogle Scholar
  • 61 Marguerie GA, Ardaillou N, Cherel G, Plow EF. The binding of fibrinogen to its platelet receptor: Involvement of the D domain. J Biol Chem 1982; 257: 11872-11875
    PubMedGoogle Scholar
  • 62 Kloczewiak M, Timmons S, Hawiger J. Recognition site for the platelet receptor is present on the 15-residue carboxy-terminal fragment of the gamma chain of human fibrinogen and is not involved in the fibrin polymerization reaction. Thromb Res 1983; 29: 249-255
    CrossrefPubMedGoogle Scholar
  • 63 Hawiger J, Timmons S, Kloczewiak M, Strong DD, Doolittle RF. Gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors. Proc Natl Acad Sci USA 1982; 79: 2068-2071
    CrossrefPubMedGoogle Scholar
  • 64 Hogg N. Human monocytes are associated with the formation of fibrin. J Exp Med 1983; 157: 473-485
    CrossrefPubMedGoogle Scholar
  • 65 Ragsdale CG, Arend WP. Characteristics of fibrinolytic enzyme release from human monocytes. Clin Exp Immunol 1981; 46: 214-224
    PubMedGoogle Scholar
  • 66 Sherman LA, Lee JL, Stewart CC. Release of fibrinolytic enzymes by macrophages in response to soluble fibrin. J Reticuloendo Soc 1981; 30: 317-329
    PubMedGoogle Scholar